Assessing the potential for precision medicine of glucose-lowering drugs in type 2 diabetes mellitus: a meta-regression analysis considering body weight variability from 120 randomized trials

Abstract Background Thus far, randomized controlled trials (RCTs) of glucose-lowering drugs reporting on treatment effects on body weight (BW) as cardiovascular risk factor in type 2 diabetes mellitus have not included precision medicine approaches. However, taking into account treatment response he...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European heart journal 2023-11, Vol.44 (Supplement_2)
Hauptverfasser:	Vargas, K G, Ruetten, T, Siemens, B, Brockmeyer, M, Parco, C, Hoss, A, Wolff, G, Roden, M, Kelm, M, Kuss, O
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!